ESLICARBAZEPINE ACETATE | SUMITOMO PHARMA AM | ||
200MG,400MG,600MG,800MG | |||
Yes | No | ||
2032-Aug-24 | 2018-Nov-08 | ||
None | None | ||
None | No | ||
APTIOM is indicated as adjunctive treatment of partial-onset seizures. |
6 | 2 | 1 |
Total Other Developers | 6 |
---|
Drugs with Suitability | No |
---|
200MG | ** | ** | Up | - | - |
400MG | ** | ** | Up | - | - |
600MG | ** | ** | Up | - | - |
800MG | ** | ** | Up | - | - |
NDA Sales Available | Total Generic Sales Available |
---|---|
Yes | 0 |
ANDA No | Generic Co | Manufacturer Name | Operations | Manufacturer Address | Country |
---|---|---|---|---|---|
****** | ****** **** *** * | ****** **** ******* | *********** | **** *, **. **.: ***, ***, *** & ***, ***** *********** ***, ********* *******, ************, ********* ******, ***** (***) | *** |
Download GenUS Drug Report
Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023
+91 94997 68112
nimish@researchdelta.com